Home › Pulmonary Arterial Hypertension › California
Pulmonary Arterial Hypertension clinical trials in California
12 studies for Pulmonary Arterial Hypertension are looking for participants at sites in California.
Cities in California
- Mountain View7 studies
- Los Angeles4 studies
- Santa Barbara3 studies
- San Francisco3 studies
- Sacramento3 studies
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- UC Davis - Medial Center ( Site 1064), Sacramento
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07218029A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA012, Los Angeles
- USA008, Santa Barbara
- USA005, Torrance
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 16, 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Cedars Sinai, Beverly Hills
- Jeffrey S. Sager, MD Medical Corporation, Santa Barbara
- Lundquist at Harbor UCLA, Torrance
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07365332Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Valley Advanced Lung Diseases Institute, Fresno
- Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
- UC Davis Health Medical Center, Sacramento
- and 1 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- UC Irvine Medical Center, Orange
- Stanford Medical Center, Stanford
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Jul 21, 2026 · NCT06649110A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
- Stanford University, Stanford
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Apr 23, 2026 · NCT06872112Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606), Los Angeles
- Stanford University School of Medicine ( Site 1603), Palo Alto
- UCSF Benioff Children's Hospital San Francisco ( Site 1611), San Francisco
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated Apr 20, 2026 · NCT05587712Pulmonary Hypertension Association Registry
- UC Davis Health, Sacramento
- UCSF Medical Center, San Francisco
- UCSF Benioff Children's Hospital, San Francisco
- and 2 more
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of California-Los Angeles, Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Stanford University Medical Center, Palo Alto
- University California San Francisco, San Francisco
RecruitingObservational study
1 Day – 21 Years · All sexes · Updated Mar 13, 2025 · NCT02249923From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.